Cargando…

Engineered NF-κB siRNA-encapsulating exosomes as a modality for therapy of skin lesions

INTRODUCTION: Despite the protection and management of skin has been paid more and more attention, effective countermeasures are still lacking for patients suffering from UV or chemotherapy with damaged skin. Recently, gene therapy by small interfering RNA (siRNA) has emerged as a new therapeutic st...

Descripción completa

Detalles Bibliográficos
Autores principales: Lu, Wei, Zhang, Jinzhong, Wu, Yungang, Sun, Wenxue, Jiang, Zipei, Luo, Xu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9945116/
https://www.ncbi.nlm.nih.gov/pubmed/36845116
http://dx.doi.org/10.3389/fimmu.2023.1109381
_version_ 1784892070231539712
author Lu, Wei
Zhang, Jinzhong
Wu, Yungang
Sun, Wenxue
Jiang, Zipei
Luo, Xu
author_facet Lu, Wei
Zhang, Jinzhong
Wu, Yungang
Sun, Wenxue
Jiang, Zipei
Luo, Xu
author_sort Lu, Wei
collection PubMed
description INTRODUCTION: Despite the protection and management of skin has been paid more and more attention, effective countermeasures are still lacking for patients suffering from UV or chemotherapy with damaged skin. Recently, gene therapy by small interfering RNA (siRNA) has emerged as a new therapeutic strategy for skin lesions. However, siRNA therapy has not been applied to skin therapy due to lack of effective delivery vector. METHODS: Here, we develop a synthetic biology strategy that integrates the exosomes with artificial genetic circuits to reprogram the adipose mesenchymal stem cell to express and assemble siRNAs into exosomes and facilitate in vivo delivery siRNAs for therapy of mouse models of skin lesions. RESULTS: Particularly, siRNA enriched exosomes (si-ADMSC-EXOs) could be directly taken up by the skin cells to inhibit the expression of skin injury related genes. When mice with skin lesions were smeared with si-ADMSC-EXOs, the repair of lesioned skin became faster and the expression of inflammatory cytokines were decreased. DISCUSSION: Overall, this study establishes a feasible therapeutic strategy for skin injury, which may offer an alternative to conventional biological therapies requiring two or more independent compounds.
format Online
Article
Text
id pubmed-9945116
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-99451162023-02-23 Engineered NF-κB siRNA-encapsulating exosomes as a modality for therapy of skin lesions Lu, Wei Zhang, Jinzhong Wu, Yungang Sun, Wenxue Jiang, Zipei Luo, Xu Front Immunol Immunology INTRODUCTION: Despite the protection and management of skin has been paid more and more attention, effective countermeasures are still lacking for patients suffering from UV or chemotherapy with damaged skin. Recently, gene therapy by small interfering RNA (siRNA) has emerged as a new therapeutic strategy for skin lesions. However, siRNA therapy has not been applied to skin therapy due to lack of effective delivery vector. METHODS: Here, we develop a synthetic biology strategy that integrates the exosomes with artificial genetic circuits to reprogram the adipose mesenchymal stem cell to express and assemble siRNAs into exosomes and facilitate in vivo delivery siRNAs for therapy of mouse models of skin lesions. RESULTS: Particularly, siRNA enriched exosomes (si-ADMSC-EXOs) could be directly taken up by the skin cells to inhibit the expression of skin injury related genes. When mice with skin lesions were smeared with si-ADMSC-EXOs, the repair of lesioned skin became faster and the expression of inflammatory cytokines were decreased. DISCUSSION: Overall, this study establishes a feasible therapeutic strategy for skin injury, which may offer an alternative to conventional biological therapies requiring two or more independent compounds. Frontiers Media S.A. 2023-02-08 /pmc/articles/PMC9945116/ /pubmed/36845116 http://dx.doi.org/10.3389/fimmu.2023.1109381 Text en Copyright © 2023 Lu, Zhang, Wu, Sun, Jiang and Luo https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Immunology
Lu, Wei
Zhang, Jinzhong
Wu, Yungang
Sun, Wenxue
Jiang, Zipei
Luo, Xu
Engineered NF-κB siRNA-encapsulating exosomes as a modality for therapy of skin lesions
title Engineered NF-κB siRNA-encapsulating exosomes as a modality for therapy of skin lesions
title_full Engineered NF-κB siRNA-encapsulating exosomes as a modality for therapy of skin lesions
title_fullStr Engineered NF-κB siRNA-encapsulating exosomes as a modality for therapy of skin lesions
title_full_unstemmed Engineered NF-κB siRNA-encapsulating exosomes as a modality for therapy of skin lesions
title_short Engineered NF-κB siRNA-encapsulating exosomes as a modality for therapy of skin lesions
title_sort engineered nf-κb sirna-encapsulating exosomes as a modality for therapy of skin lesions
topic Immunology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9945116/
https://www.ncbi.nlm.nih.gov/pubmed/36845116
http://dx.doi.org/10.3389/fimmu.2023.1109381
work_keys_str_mv AT luwei engineerednfkbsirnaencapsulatingexosomesasamodalityfortherapyofskinlesions
AT zhangjinzhong engineerednfkbsirnaencapsulatingexosomesasamodalityfortherapyofskinlesions
AT wuyungang engineerednfkbsirnaencapsulatingexosomesasamodalityfortherapyofskinlesions
AT sunwenxue engineerednfkbsirnaencapsulatingexosomesasamodalityfortherapyofskinlesions
AT jiangzipei engineerednfkbsirnaencapsulatingexosomesasamodalityfortherapyofskinlesions
AT luoxu engineerednfkbsirnaencapsulatingexosomesasamodalityfortherapyofskinlesions